Beta blockers should still be used in patients with COPD despite negative trial results showing they do not reduce exacerbations in patients without cardiovascular indications, researchers say. Published in the NEJM, findings from the BLOCK COPD trial showed that metoprolol had no effect on the primary outcome of time until the first COPD exacerbation in patients ...
Don’t let negative results deter beta blocker use in COPD
By Michael Woodhead
24 Oct 2019